Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

US Pharmaceuticals Ishares ETF (IHE)

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 354,552,000
  • Market Capitalization, $K 354,552
  • Shares Outstanding, K 2,200
  • 60-Month Beta 1.05
  • Price/Earnings ttm 29.17
  • Annual Dividend & Yield 2.24 (1.39%)
  • Most Recent Dividend 0.515 on 12/16/19
  • Management Fee 0.42%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
158.00 +2.02%
on 01/27/20
165.70 -2.72%
on 01/16/20
-1.55 (-0.95%)
since 01/14/20
3-Month
144.11 +11.85%
on 11/15/19
165.70 -2.72%
on 01/16/20
+17.38 (+12.09%)
since 11/14/19
52-Week
136.66 +17.95%
on 10/02/19
165.70 -2.72%
on 01/16/20
+11.05 (+7.36%)
since 02/14/19

Most Recent Stories

More News
Pharma ETFs Gain on Healthy Q4 Earnings

Strong results led to solid trading in pharma ETFs over the past week.

PPH : 66.42 (-0.32%)
PJP : 65.27 (-0.18%)
XPH : 46.70 (+0.06%)
IHE : 161.19 (+0.11%)
FTXH : 23.64 (-0.17%)
4 Sector ETFs Sizzling With Solid Buybacks

Inside the sectors that have seen strong share buybacks in the past 10 years.

WFC : 48.22 (+0.21%)
JPM : 137.46 (-0.30%)
C : 78.79 (-0.27%)
BAC : 34.85 (-0.17%)
AAP : 133.59 (-0.80%)
ORCL : 55.47 (+0.29%)
MSFT : 185.35 (+0.89%)
MS : 55.84 (-0.16%)
IHE : 161.19 (+0.11%)
XLF : 31.17 (+0.13%)
MCD : 217.09 (-0.15%)
SBUX : 89.28 (-0.72%)
INTC : 67.27 (-0.25%)
V : 210.29 (+1.39%)
MA : 340.95 (+1.52%)
4 Sector ETFs Sizzling With Solid Buybacks

Inside the sectors that have seen strong share buybacks in the past 10 years.

JPM : 137.46 (-0.30%)
WFC : 48.22 (+0.21%)
C : 78.79 (-0.27%)
BAC : 34.85 (-0.17%)
AAP : 133.59 (-0.80%)
ORCL : 55.47 (+0.29%)
MSFT : 185.35 (+0.89%)
SLI : 39.99 (+0.05%)
MS : 55.84 (-0.16%)
IHE : 161.19 (+0.11%)
XLY : 131.69 (-0.15%)
XLF : 31.17 (+0.13%)
MCD : 217.09 (-0.15%)
SBUX : 89.28 (-0.72%)
INTC : 67.27 (-0.25%)
V : 210.29 (+1.39%)
M : 16.67 (-0.42%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

PPH : 66.42 (-0.32%)
NVO : 63.45 (+1.13%)
ABBV : 94.05 (-1.36%)
BMY : 66.38 (+0.45%)
PJP : 65.27 (-0.18%)
IHE : 161.19 (+0.11%)
Pharma ETFs Set to Benefit Post Strong Q3 Earnings

Robust results led to solid trading in pharma ETFs in a month.

XPH : 46.70 (+0.06%)
PJP : 65.27 (-0.18%)
PPH : 66.42 (-0.32%)
IHE : 161.19 (+0.11%)
FTXH : 23.64 (-0.17%)
JNJ Beats, Ups View: Healthcare ETFs to Buy

Johnson & Johnson continued its long streak of earnings beat and outpaced revenue estimates. It also raised its guidance for the full year.

JNJ : 150.13 (+0.03%)
XLV : 103.93 (+0.08%)
IYH : 220.73 (+0.20%)
IHE : 161.19 (+0.11%)
VHT : 196.69 (+0.23%)
IEIH : 28.63 (+0.07%)
Pharma Q2 Earnings Growth Highest: Time to Buy ETFs?

Despite robust results, pharma ETFs have been trending downward in a month.

PJP : 65.27 (-0.18%)
XPH : 46.70 (+0.06%)
PPH : 66.42 (-0.32%)
IHE : 161.19 (+0.11%)
FTXH : 23.64 (-0.17%)
Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat

Johnson & Johnson beat the second-quarter earnings and revenue estimates but warned on competition from generics and biosimilars that could impact its third-quarter results.

JNJ : 150.13 (+0.03%)
IHE : 161.19 (+0.11%)
XLV : 103.93 (+0.08%)
IYH : 220.73 (+0.20%)
VHT : 196.69 (+0.23%)
IEIH : 28.63 (+0.07%)
AbbVie to Buy Allergan: Prescribed ETFs

AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.

BMY : 66.38 (+0.45%)
AGN : 198.32 (-0.47%)
ABBV : 94.05 (-1.36%)
BBH : 143.22 (+0.53%)
PPH : 66.42 (-0.32%)
XPH : 46.70 (+0.06%)
IHE : 161.19 (+0.11%)
PJP : 65.27 (-0.18%)
CELG : 108.24 (+0.10%)
Pharma ETFs Down Despite Solid Q1 Results

Despite such robust results, pharma ETFs have been trending downward in a month.

XPH : 46.70 (+0.06%)
PJP : 65.27 (-0.18%)
IHE : 161.19 (+0.11%)
PPH : 66.42 (-0.32%)
FTXH : 23.64 (-0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade IHE with:

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 162.14
1st Resistance Point 161.67
Last Price 161.19
1st Support Level 160.72
2nd Support Level 160.24

See More

52-Week High 165.70
Last Price 161.19
Fibonacci 61.8% 154.61
Fibonacci 50% 151.18
Fibonacci 38.2% 147.75
52-Week Low 136.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar